Bryan Oronsky

Bryan Oronsky

Company: EpicentRx

Job title: Chief Medical Officer


Navigating Clinical & Post-Approval Considerations for Inflammasome Inhibitors with Diverse Uses and Future Implications 9:30 am

Gain insights into the advanced stage of development for novel inflammasome inhibitors Examine the broader implications of inflammasome inhibitor approvals, including offlabel usage considerations, insurance coverage challenges, and their impact on existing treatment paradigm Explore how the approval and widespread adoption of inflammasome inhibitors may disrupt traditional therapeutic approaches, particularly in comparison to corticosteroidsRead more

day: Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.